Published in J Exp Med on July 01, 1988
Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis. Immunology (1991) 0.78
Effects of interleukin-2 and interleukin-2-activated cells on in vitro myelopoiesis. Clin Exp Immunol (1990) 0.77
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med (1981) 5.76
Response of resting human peripheral blood natural killer cells to interleukin 2. J Exp Med (1984) 5.26
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med (1986) 3.99
Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med (1986) 2.70
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med (1985) 2.11
Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes. Annu Rev Immunol (1986) 2.08
Increase in circulating stem cells following chemotherapy in man. Blood (1976) 1.58
Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J Immunol (1982) 1.30
Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J Exp Med (1985) 1.19
Natural killer cells suppress human erythroid stem cell proliferation in vitro. Blood (1984) 1.15
High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation. Br J Haematol (1984) 1.04
In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. Blood (1987) 0.98
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol (1986) 0.94
Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning"). Blood (1985) 0.89
Successful haematopoietic reconstitution using autologous peripheral blood mononucleated cells in a patient with acute promyelocytic leukaemia. Br J Haematol (1986) 0.85
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04
Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (1989) 9.01
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol (1983) 6.39
Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood (2000) 6.27
Immune inhibitory receptors. Science (2000) 6.05
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol (1986) 5.27
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature (1998) 4.86
Human diversity in killer cell inhibitory receptor genes. Immunity (1997) 4.82
An activating immunoreceptor complex formed by NKG2D and DAP10. Science (1999) 4.56
Natural killer cells, viruses and cancer. Nat Rev Immunol (2001) 4.21
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med (1986) 3.99
Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity (2000) 3.84
Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity (1997) 3.84
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70
CD28- T lymphocytes. Antigenic and functional properties. J Immunol (1993) 3.67
B70 antigen is a second ligand for CTLA-4 and CD28. Nature (1993) 3.57
The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med (1995) 3.43
Applications of retrovirus-mediated expression cloning. Exp Hematol (1996) 3.40
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39
Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma (1982) 3.36
Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol (1989) 3.28
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A (2001) 3.21
Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01
Co-association of CD3 zeta with a receptor (CD16) for IgG Fc on human natural killer cells. Nature (1989) 2.91
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity (2000) 2.75
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med (1992) 2.70
The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol (1984) 2.70
Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol (1994) 2.69
The importance of the zygomatic arch in complex midfacial fracture repair and correction of posttraumatic orbitozygomatic deformities. Plast Reconstr Surg (1990) 2.68
The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity (1998) 2.68
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66
Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J Immunol (1995) 2.63
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med (1994) 2.59
DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 2.56
Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity (1998) 2.54
The T cell antigen receptor complex expressed on normal peripheral blood CD4-, CD8- T lymphocytes. A CD3-associated disulfide-linked gamma chain heterodimer. J Exp Med (1987) 2.52
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med (1994) 2.47
Natural killer cells: definition of a cell type rather than a function. J Immunol (1986) 2.46
Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science (1995) 2.44
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics (2001) 2.43
Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today (1996) 2.42
CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol (1995) 2.28
Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. J Immunol (1985) 2.20
Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus. Nature (1987) 2.20
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med (1989) 2.17
Structure, function, and serology of the T-cell antigen receptor complex. Annu Rev Immunol (1987) 2.17
p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol (1985) 2.14
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med (1994) 2.14
Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol (1996) 2.13
Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol (2001) 2.09
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol (1998) 2.06
Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor beta chain genes. J Exp Med (1986) 2.01
Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol (1988) 2.00
Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med (1993) 1.98
The syndrome of papillary muscle dysfunction. Am Heart J (1968) 1.96
Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med (1988) 1.95
Activation of natural killer cells via the p75 interleukin 2 receptor. J Exp Med (1989) 1.95
Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med (1993) 1.93
Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity (2000) 1.92
Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev (2001) 1.88
Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol (1988) 1.88
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
Arousal and inhibition of human NK cells. Immunol Rev (1997) 1.87
Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol (1997) 1.86
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A (1999) 1.86
LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity (1997) 1.85
Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol (1986) 1.83